Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
Clinical trial NCT02332954 · COMPLETED
Trial details
- NCT number
- NCT02332954
- Sponsor
- Lundbeck Canada Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-07-06
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.